Linda Malek
Overview
Linda Malek is a partner in Crowell & Moring’s Health Care and Privacy and Cybersecurity groups in New York, and a managing director at Crowell Health Solutions. She advises a broad array of health care and life sciences clients on compliance with federal, state, and international law governing clinical research, data privacy, cybersecurity, and fraud and abuse. Her clients include national hospital systems and academic medical centers; genetic, health technology, and biotechnology companies; pharmaceutical companies; medical device companies; financial institutions involved in health care services; research foundations; and international scientific organizations.
Career & Education
- New York
Office of the Corporation Counsel, Division of Legal Counsel, 1993–1999
- New York
- Walla Walla University, B.A., cum laude
- University of Virginia School of Law, J.D.,
Editorial Board Member, Journal of Law and Politics
Recipient, Mary Claiborne and Roy H. Ritter Award, The University of Virginia School of Law
- New York
- Board Member, NYBIO
- Trustee, Lucy B. Moses Foundation
- Former member of Educational Advisory Board, International Association of Privacy Professionals
- Founding Board, National Board of Health Lawyers, a division of NBTA (National Board of Trial Advocacy)
- American Bar Association, Health Reform Task Force
- American Health Lawyers Association
- French
Linda's Insights
Webinar | 10.16.25
The landscape of AI governance and regulation is shifting. Following the release of the White House’s “America’s AI Action Plan” in July 2025 and the President’s signing of related Executive Orders, the White House has emphasized (at least rhetorically) a preference for innovation, adoption, and deregulation. But that does not tell the entire story. The Administration remains committed to exercising a heavy hand in AI, including by banning the U.S. government’s procurement of so-called “woke AI,” intervening in the development of data centers and the export of the AI technology stack, imposing an export fee for certain semiconductors to China, and assuming a stake in a U.S. semiconductor company. State legislatures are also racing to implement their own regulations, particularly around AI’s use in critical areas, such as healthcare, labor and employment, and data privacy. The many sources of regulation raise the specter of a fragmented compliance environment for businesses. This webinar will delve into the Administration’s AI strategy, going beyond the headlines to analyze:
Webinar | 09.25.25
Client Alert | 5 min read | 08.26.25
Firm News | 9 min read | 08.21.25
Recognition
- Chambers USA: Healthcare, New York, 2024–2025
- Best Lawyers in America: 2022–2024, 2026
- Super Lawyers: 2013–2024
Linda's Insights
Webinar | 10.16.25
The landscape of AI governance and regulation is shifting. Following the release of the White House’s “America’s AI Action Plan” in July 2025 and the President’s signing of related Executive Orders, the White House has emphasized (at least rhetorically) a preference for innovation, adoption, and deregulation. But that does not tell the entire story. The Administration remains committed to exercising a heavy hand in AI, including by banning the U.S. government’s procurement of so-called “woke AI,” intervening in the development of data centers and the export of the AI technology stack, imposing an export fee for certain semiconductors to China, and assuming a stake in a U.S. semiconductor company. State legislatures are also racing to implement their own regulations, particularly around AI’s use in critical areas, such as healthcare, labor and employment, and data privacy. The many sources of regulation raise the specter of a fragmented compliance environment for businesses. This webinar will delve into the Administration’s AI strategy, going beyond the headlines to analyze:
Webinar | 09.25.25
Client Alert | 5 min read | 08.26.25
Firm News | 9 min read | 08.21.25
Insights
- |
08.01.25
Journal of Federal Agency Action
Proposed Rule On Protecting Bulk Sensitive Data And Its Impact On Health Care
|12.06.24
Westlaw Today
How Health Cos. Can Brace For Tracking Tech Scrutiny
|08.24.23
Law360
Theories of AI Liability: It’s Still About the Human Element
|09.20.22
Reuters
Data Privacy and Artificial Intelligence in Health Care
|03.17.22
Reuters
Government Oversight in Managing Risks of AI in Health Care
|01.12.22
Reuters
Significance of FTC Guidance on Artificial Intelligence in Health Care
|11.24.21
Reuters Legal
INSIGHT: Advice for Digital Health Developers During Covid-19
|05.05.20
Bloomberg Law
Proposed Privacy Laws Put Genetic Testing Cos. In Hot Seat
|02.24.20
Law360
Higher Education & Healthcare Research Compliance Conference
|06.12.24
"Spotlight on Health Equity in Clinical Trials," 2nd Annual Westchester Life Sciences Showcase, New York
|05.01.24
DOJ Official Calls Uber Security Chief Conviction An 'Outlier'
|12.09.22
Law360
Why FDA's Medical Device Cyber Recommendations 'Have Teeth'
|05.27.22
Healthcare Info Security
3 Key Details To Watch As Congress Mulls Breach Report Law
|12.24.21
Law360
Protecting AI in Healthcare: Addressing Algorithmic Bias, Data Privacy, Security
|07.18.22
Healthcare Strategies
2022 Expert Predictions Part Two: Digital Health Solutions, Security Trends
|01.10.22
Healthcare Strategies
- |
08.01.25
Crowell & Moring’s Government Contracts Legal Forum
- |
01.30.25
Crowell Health Solution’s Trends in Transformation
FDA Proposes Framework to Assess AI Model Output Credibility to Support Regulatory Decision-Making
|01.29.25
Crowell & Moring’s Health Law Blog
FDA Calls Out a Migraine TV Ad for Misleading Viewers
|10.17.24
Crowell Health Solution’s Trends in Transformation
FDA Publishes FAQs Around Its Recent Laboratory Developed Tests Final Rule
|08.12.24
Crowell Health Solution’s Trends in Transformation
FDA Issues Guidance on Using Electronic Health Records and Medical Claims Data in Clinical Studies
|08.01.24
Crowell Health Solution’s Trends in Transformation
New Federal Guidelines for Research Security Programs at Covered Institutions
|07.22.24
Crowell Health Solution’s Trends in Transformation
- |
07.16.24
Crowell Health Solution’s Trends in Transformation
Linda's Insights
Webinar | 10.16.25
The landscape of AI governance and regulation is shifting. Following the release of the White House’s “America’s AI Action Plan” in July 2025 and the President’s signing of related Executive Orders, the White House has emphasized (at least rhetorically) a preference for innovation, adoption, and deregulation. But that does not tell the entire story. The Administration remains committed to exercising a heavy hand in AI, including by banning the U.S. government’s procurement of so-called “woke AI,” intervening in the development of data centers and the export of the AI technology stack, imposing an export fee for certain semiconductors to China, and assuming a stake in a U.S. semiconductor company. State legislatures are also racing to implement their own regulations, particularly around AI’s use in critical areas, such as healthcare, labor and employment, and data privacy. The many sources of regulation raise the specter of a fragmented compliance environment for businesses. This webinar will delve into the Administration’s AI strategy, going beyond the headlines to analyze:
Webinar | 09.25.25
Client Alert | 5 min read | 08.26.25
Firm News | 9 min read | 08.21.25